BioStock: BiBBInstruments brings new vision to cancer diagnostics
Despite the advancements made in cancer therapeutics over the last decade, cancer remains one of the top causes of death worldwide. Early detection plays a big role in keeping the cancer death rates low, and Swedish medtech BiBBInstruments is addressing the issue with its EndoDrill Model X, the first CE-marked electric endoscopic biopsy device. The device can provide better tumour samples, which can result in a more complete and accurate cancer diagnosis and thus lead to earlier treatment in patients afflicted by some of the most serious cancers. BioStock spoke with the company’s CEO Fredrik Lindblad to learn more about BiBBInstrument and the EndoDrill Model X.
Read the full interview with BiBBInstrument's CEO Fredrik Lindblad at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se